Nationwide Fund Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-250	Closed	-$137K	–	1665
2017 Q3	$137K	Buy	250 +30	+14%	+$16.4K	﹤0.01%	2781
2017 Q2	$131K	Buy	220 +152	+224%	+$90.5K	﹤0.01%	2791
2017 Q1	$29K	Buy	+68	New	+$29K	﹤0.01%	3057